Azzalure injections contain the active ingredient botulinum toxin type A, which is a toxin produced by the bacteria Clostridium botulinum.Botulinum toxin type A is a bacterial toxin that prevents nerves from functioning normally (a neurotoxin). It prevents nerves from releasing a chemical called acetylcholine, which is essential for the nerves to communicate with muscle cells. This toxin therefore prevents muscles from receiving nerve stimulation.
Preventing nerve stimulation of muscles causes the muscles to become paralysed. Botulinum toxin type A causes muscle paralysis until such time as the nerve develops new endings to communicate with the muscles.Buy Azzalure Australia
Buy Azzalure Australia
Azzalure injections are administered into the muscle above and between the eyebrows to temporarily paralyse and relax these muscles. They are used to cosmetically improve the appearance of vertical frown lines between the eyebrows.These injections only provide a short-term improvement. They are only used when the appearance of frown lines is prominent and is having an important psychological effect on an individual.
Use with caution in
- People with inflammation in the area to be injected.
- People with excessive weakness or wasting in the muscle to be injected.
- People at risk of bleeding after an injection into a muscle, for example due to blood clotting disorders such as haemophilia, or treatment with anticoagulant medicines.
- People with a history of swallowing difficulties (dysphagia), or food or liquid accidentally going into the lungs (aspiration).
- People with chronic breathing difficulties.
- Diseases or conditions affecting the nervous system and muscles (neuromuscular conditions) for example motor neuropathy, in which there is progressive degeneration of the nerves that activate the muscles.
- People who have recently had surgery or are due to have surgery in the near future.
- People who have recently had an operation or injury to the head, neck or chest.
Not to be used in
- People with an infection at the site of injection.
- People who have previously had an allergic reaction to botulinum toxin type A injections.
- Abnormal muscle weakness (myasthenia gravis)
- Chronic disease affecting the muscles (Eaton Lambert syndrome).
- A condition called amyotrophic lateral sclerosis, in which there is progressive degeneration of the nerves that
- activate the muscles.
- People over 65 years old.
- Children under the age of 18 years.